Sample. V18.2 Special Report: Postpartum Readmissions What Drives Your Rate?

Size: px
Start display at page:

Download "Sample. V18.2 Special Report: Postpartum Readmissions What Drives Your Rate?"

Transcription

1 V18.2 Special Report: Postpartum Readmissions What Drives Your Rate? INTRODUCTION In FY 2013, the Center for Medicare and Medicaid Services (CMS) began the Hospital Readmission Reduction Program (HRRP) to reduce frequent readmissions for patients with Acute Myocardial Infarction (AMI), Chronic Obstructive Pulmonary Disease (COPD), Heart Failure (HF), Pneumonia, and Coronary Artery Bypass Graft (CABG) Surgery. 1 The Program initiated a reduction in Medicare reimbursement for high readmission hospitals, assuming that a financial penalty would change how hospitals manage at-risk patients prior to and post-discharge. Perinatal readmissions, while not included in HRRP and far less common, have not been without scrutiny. Any maternal or neonatal readmission is a concern. Post-birth separation impacts maternal/infant/family bonding and breastfeeding, and often creates general anxiety for the family. Most providers will look to avoid a readmission for just those reasons. Adding a financial penalty in an attempt to reduce readmissions, however, may assume a level of provider control that is misplaced. Clapp et al 2, recently reported on a retrospective study they conducted using State Inpatient databases from California, Florida and New York to determine the relative effects of patient and hospital factors on maternal postpartum readmissions. The authors recognized that while reimbursement penalties for readmissions have not yet been applied to obstetrics, hospitals with higher readmission rates may be penalized for patient factors outside the control of their health care providers. The goal of the study was to compare the patient, delivery, and hospital characteristics of low readmission hospitals to those of high readmission hospitals. The researchers hypothesized that patient factors, not hospitals factors, would drive higher readmission rates. Patient factors included common comorbidities affecting pregnant women (obesity, hypertension, diabetes, etc.). Hospital characteristics included teaching status (major, minor, nonteaching), profit status (profit, not-for-profit, public) and community status. Community hospitals were defined as short term, non-federal hospitals. Hospitals were also classified by their delivery volume quartile. Readmission rates for each hospital were calculated over the entire period for each state. V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 1

2 Data encompassed the time period from for Florida and New York, and from for California. High readmission hospitals were those in the top quartile for readmissions, and low readmission hospitals were in the bottom quartile. In California, low readmission hospitals had an average rate of 0.75% and high readmission hospitals had an average rate of 1.34%. In Florida, low readmission hospitals had a rate of 1.14% and high readmission hospitals had a rate of 2.00%. In New York, low readmission hospitals had a rate of 0.88% and high readmission hospitals had a rate of 2.26%. Women in low readmission hospitals were more likely to be white, have private insurance, and have higher median incomes. All identified comorbidity rates were higher in the high readmission hospitals, with the most prevalent conditions being pregnancyrelated hypertension and diabetes. There were higher rates of peripartum complication in the high readmission hospitals, with the highest rates being hemorrhage and higher-order lacerations. Cesarean delivery and delivery complications such as operative injury and uterine rupture had a high risk of readmission. In comparison to low readmission hospitals, more patients were cared for at major teaching hospitals in the high readmission group. In this study, perinatal readmissions were more attributable to patient and demographic characteristics than to hospital characteristics. The authors concluded that postpartum readmission metric-based incentives may ultimately penalize hospitals providing high quality care due to patient characteristics specific to their catchment area 3 and largely beyond their immediate control. V18.2 SPEICAL REPORT This Special Report does not attempt to replicate the Clapp study. It is designed to show readmission rates for your hospital compared to the readmission rates of all eight NPIC peer subgroups and the NPIC overall average. The NPIC subgroups reflect differences in academic status and level of care (basic, specialty or subspecialty), and generally track to volume of perinatal discharges. These subgroupings profile hospital characteristics similar to those identified in the Clapp study, so we were curious to see if the differences in maternal readmission rates would be higher for the more complex hospitals and if the profile of patients would indeed reflect more complex patients (at greater risk of readmission). DESCRIPTION OF TABLE The Table accompanying this special report displays your hospital s data in comparison to all NPIC subgroups and the entire NPIC database average. Your subgroup column is highlighted in grey. Section A of the Table shows your total delivery volume, your postpartum readmission rate, the case mix index of all your delivery cases for the period 7/1/2017-6/30/2018, and your adjusted readmission rate. The adjusted readmission rate is calculated by dividing your actual readmission V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 2

3 rate by your case mix index. Your case mix index is a reflection of the acuity of your delivery population, and your adjusted readmission rate neutralizes the impact of your differential acuity and allows for comparison of case mix neutral rates across subgroups. Section B of the Table displays the profile of your delivery population patient characteristics similar to those discussed in the Clapp study: race, payer mix, maternal comorbidities and pregnancy characteristics. All of the ICD-10 codes used to drive the definition of the numerator cases are listed in Appendix A. DISCUSSION The average maternal readmission rates across the eight NPIC subgroups range from 0.65% to 1.37%, compared to the range noted in the Clapp study of 0.75% (low readmission hospitals in CA) and 2.26% (high readmission hospitals in NY). The lower range of rates for the NPIC subgroups may be a reflection of the timing of the analyses ( for the study hospitals vs. 7/2017-6/2018 for the NPIC hospitals). We also speculate that the NPIC member hospitals are somewhat unique in their on-going interest in QI and attention to national trends in issues surrounding perinatal care. The difference in maternal readmission rates across the eight NPIC subgroups seems to follow the pattern identified by Clapp et al. The Academic Regional (AR) subgroup has the highest readmission rate for the period as well as the highest adjusted readmission rate, even though their case mix index is slightly lower than the Academic Specialty (AS) and Georgia (G) subgroups. If we focus our attention on the AR subgroup in comparison to the Newborn Basic (NB) level I subgroup, we note the following: Maternal comorbidity rates are higher in the AR subgroup compared to the NB subgroup for all those listed except for obesity and tobacco use. Pregnancy characteristics of multiple gestation, Preterm labor/delivery and abnormal placentation are notably higher in the AR subgroup compared to the NB subgroup. Prior cesarean delivery rates are comparable for the two subgroups. Overall the non-academic Intermediate (NI) and non-academic Basic (NB) subgroups have lower rates of maternal complications and pregnancy characteristics and lower readmission rates, consistent with the general findings of the study. Questions regarding this Special Report should be directed to Sandra Boyle, Director of Data Services (sboyle@npic.org) or Tara Wilcox, Senior Analyst/ Hospital Liaison (twilcox@npic.org). REFERENCES Clapp M. A, Little, S.E., Zheng, J., Robinson, J. N., Kaimal, J.A. The Relative Effects of Patient and Hospital Characteristics on Perinatal Readmissions, Journal of Perinatology (2018) 38: Clapp, Op. cit. V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 3

4 V18.2 Special Report: Postpartum Readmissions Hospital Subgroup Averages NPIC Database SA1 AR AS NR NS NI NB G CWISH Average A. Postpartum Readmissions Total Deliveries 2,612 3,785 5,388 3,452 2,149 1, ,692 8,716 3,726 Total Postpartum Readmissions within 30 days post-discharge* Postpartum Readmission Rate 1.31% 1.36% 1.12% 1.10% 0.74% 0.81% 0.65% 1.21% 1.22% 1.04% Case Mix Index - All deliveries Case Mix Adjusted Postpartum Readmission Rate 2.75% 2.95% 2.44% 2.49% 1.70% 1.90% 1.51% 2.59% 2.72% 2.31% B. Delivery Patient Characteristics (% of total deliveries) B1. Race White 55.0% 54.7% 59.6% 61.7% 61.3% 69.4% 65.3% 33.2% 40.5% 55.9% Black 41.5% 20.1% 19.9% 16.9% 17.0% 8.7% 15.9% 55.1% 14.9% 19.5% Asian 0.0% 5.7% 4.9% 3.9% 5.1% 6.4% 5.1% 1.2% 9.9% 5.6% Native American 0.2% 0.8% 0.2% 1.0% 0.3% 2.1% 0.7% 0.1% 0.2% 0.7% Other 0.0% 1.7% 2.2% 1.8% 2.4% 1.9% 2.5% 3.5% 8.7% 3.2% Unknown/Missing 3.3% 17.2% 13.2% 14.7% 13.9% 11.6% 10.6% 7.0% 25.7% 15.1% B2. Payer mix Private 53.0% 60.2% 56.9% 52.7% 56.5% 64.0% 49.8% 32.0% 63.1% 56.1% Public 46.8% 31.7% 34.6% 41.1% 40.0% 34.1% 48.4% 62.9% 31.7% 38.8% Uninsured/self pay 0.3% 0.6% 1.9% 3.1% 2.7% 1.4% 1.6% 3.4% 2.4% 2.1% Other 0.0% 7.1% 6.1% 2.8% 0.8% 0.3% 0.2% 0.4% 1.7% 2.5% Unknown/Missing 0.0% 0.3% 0.5% 0.3% 0.1% 0.3% 0.0% 1.2% 1.1% 0.5% B3. Maternal comorbidities Obesity 25.3% 14.9% 15.8% 12.6% 7.9% 8.3% 15.9% 14.3% 11.2% 12.0% Hypertensive disorder 4.2% 4.2% 3.5% 2.6% 2.4% 2.1% 2.8% 7.2% 3.0% 3.3% Pregnancy related hypertensive disorder 14.6% 16.0% 14.3% 10.9% 9.4% 10.4% 11.2% 15.7% 12.0% 12.3% Diabetes 10.5% 10.5% 9.5% 8.4% 9.3% 7.3% 8.7% 9.0% 10.1% 9.2% Asthma 9.7% 8.3% 8.7% 5.6% 5.1% 5.4% 6.5% 7.2% 6.5% 6.5% Tobacco Use 6.4% 4.2% 3.6% 5.1% 4.2% 5.3% 6.9% 6.2% 3.3% 4.6% Thyroid disease 8.9% 8.1% 7.1% 5.9% 5.5% 5.2% 5.5% 4.6% 7.1% 6.2% Psychiatric disease 6.4% 9.5% 8.2% 6.1% 5.6% 6.9% 8.0% 7.7% 7.3% 7.3% Seizure disorder 2.3% 2.3% 2.1% 1.3% 1.1% 1.3% 1.6% 2.5% 2.4% 1.8% B4. Pregnancy characteristics Multiple gestation 2.8% 2.8% 2.3% 1.8% 1.5% 1.0% 1.0% 2.9% 2.2% 1.9% Prior cesarean delivery 19.0% 17.6% 19.6% 19.1% 19.1% 16.6% 17.8% 19.5% 18.2% 18.3% Preterm labor/delivery 12.2% 8.9% 7.2% 6.9% 6.0% 4.3% 4.7% 11.7% 6.8% 7.0% Abnormal placentation 2.1% 2.6% 1.9% 1.7% 1.7% 1.4% 1.4% 2.5% 2.0% 1.9% * Total deliveries discharged to home (with or without home health) and readmitted within 30 days Date Range of Hospital Data: 7/1/2017-6/30/2018 Subgroup: AR - Academic Regional Date Range of Comparison Data: 7/1/2017-6/30/2018 NPIC.ORG 4

5 Obesity O Obesity complicating pregnancy, unspecified trimester O Obesity complicating pregnancy, first trimester O Obesity complicating pregnancy, second trimester O Obesity complicating pregnancy, third trimester O Obesity complicating childbirth O Obesity complicating the puerperium Z68.30 Body mass index (BMI) , adult Z68.31 Body mass index (BMI) , adult Z68.32 Body mass index (BMI) , adult Z68.33 Body mass index (BMI) , adult Z68.34 Body mass index (BMI) , adult Z68.35 Body mass index (BMI) , adult Z68.36 Body mass index (BMI) , adult Z68.37 Body mass index (BMI) , adult Z68.38 Body mass index (BMI) , adult Z68.39 Body mass index (BMI) , adult Z68.41 Body mass index (BMI) , adult Z68.42 Body mass index (BMI) , adult Z68.43 Body mass index (BMI) , adult Z68.44 Body mass index (BMI) , adult Z68.45 Body mass index (BMI) 70 or greater, adult Hypertensive Disorder O10 Pre existing hypertension complicating pregnancy, childbirth, and the puerperium O Pre existing essential hypertension complicating pregnancy, first trimester O Pre existing essential hypertension complicating pregnancy, second trimester O Pre existing essential hypertension complicating pregnancy, third trimester O Pre existing essential hypertension complicating pregnancy, unspecified trimester O10.02 Pre existing essential hypertension complicating childbirth O10.03 Pre existing essential hypertension complicating the puerperium O Pre existing hypertensive heart disease complicating pregnancy, first trimester O Pre existing hypertensive heart disease complicating pregnancy, second trimester O Pre existing hypertensive heart disease complicating pregnancy, third trimester O Pre existing hypertensive heart disease complicating pregnancy, unspecified trimester O10.12 Pre existing hypertensive heart disease complicating childbirth O10.13 Pre existing hypertensive heart disease complicating the puerperium O Pre existing hypertensive chronic kidney disease complicating pregnancy, first trimester O Pre existing hypertensive chronic kidney disease complicating pregnacy, second trimester O Pre existing hypertensive chronic kidney disease complicating pregnancy, third trimester O Pre existing hypertensive chronic kidney disease complicating pregnancy, unspecified trimester O10.22 Pre existing hypertensive chronic kidney disease complicating childbirth O10.23 Pre existing hypertensive chronic kidney disease complicating the puerperium O Pre existing hypertensive heart and chronic kidney disease complicating pregnancy, first trimester O Pre existing hypertensive heart and chronic kidney disease complicating pregnancy, second trimester V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 5

6 Hypertensive Disorder (con.'t) O Pre existing hypertensive heart and chronic kidney disease complicating pregnancy, third trimester O Pre existing hypertensive heart and chronic kidney disease complicating pregnancy, unspecified trimester O10.32 Pre existing hypertensive heart and chronic kidney disease complicating childbirth O10.33 Pre existing hypertensive heart and chronic kidney disease complicating the puerperium O Pre existing secondary hypertension complicating pregnancy, first trimester O Pre existing secondary hypertension complicating pregnancy, second trimester O Pre existing secondary hypertension complicating pregnancy, third trimester O Pre existing secondary hypertension complicating pregnancy, unspecified trimester O10.42 Pre existing secondary hypertension complicating childbirth O10.43 Pre existing secondary hypertension complicating the puerperium O Unspecified pre existing hypertension complicating pregnancy, first trimester O Unspecified pre existing hypertension complicating pregnancy, second trimester O Unspecified pre existing hypertension complicating pregnancy, third trimester O Unspecified pre existing hypertension complicating pregnancy, unspecified trimester O10.92 Unspecified pre existing hypertension complicating childbirth O10.93 Unspecified pre existing hypertension complicating the puerperium O11 Pre existing hypertension with pre eclampsia O11.1 Pre existing hypertension with pre eclampsia, first trimester O11.2 Pre existing hypertension with pre eclampsia, second trimester O11.3 Pre existing hypertension with pre eclampsia, third trimester O11.4 Pre existing hypertension with pre eclampsia, complicating childbirth O11.5 Pre existing hypertension with pre eclampsia, complicating the puerperium O11.9 Pre existing hypertension with pre eclampsia, unspecified trimester Pregnancy Related Hypertensive Disorder O13 Gestational [pregnancy induced] hypertension without significant proteinuria O13.1 Gestational hypertension w/o significant proteinuria, first trimester O13.2 Gestational hypertension w/o significant proteinuria, second trimester O13.3 Gestational hypertension w/o significant proteinuria, third trimester O13.4 Gestational [pregnancy induced] hypertension without significant proteinuria, complicating child birth. O13.5 Gestational (pregnancy induced) hypertension without significant proteinuria, complicating the puerperium O13.9 Gestational [pregnancy induced] hypertension without significant proteinuria, unspecified trimester O14 Pre eclampsia O14.00 Mild to moderate pre eclampsia, unspecifed trimester O14.02 Mild to moderate pre eclampsia, second trimester O14.03 Mild to moderate pre eclampsia, third trimester O14.04 Mild to moderate pre eclampsia, complicating childbirth O14.05 Mild to moderate pre eclampsia, complicating the puerperium O14.10 Severe pre eclampsia, unspecified trimester O14.12 Severe pre eclampsia, second trimester O14.13 Severe pre eclampsia, third trimester O14.14 Severe pre eclampsia complicating childbirth O14.15 Severe pre eclampsia, complicating the puerperium O14.20 HELLP syndrome (HELLP), unspecified trimester V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 6

7 Pregnancy Related Hypertensive Disorder (con.'t) O14.22 HELLP syndrome (HELLP), second trimester O14.23 HELLP syndrome (HELLP), third trimester O14.24 HELLP syndrome, complicating childbirth O14.25 HELLP syndrome, complicating the puerperium O14.90 Unspecified pre eclampsia, unspecified trimester O14.92 Unspecified pre eclampsia, second trimester O14.93 Unspecified pre eclampsia, third trimester O14.94 Unspecified pre eclampsia, complicating childbirth O14.95 Unspecified pre eclampsia, complicating the puerperium O15 Eclampsia O15.00 Eclampsia in pregnancy, unspecified trimester O15.02 Eclampsia in pregnancy, second trimester O15.03 Eclampsia in pregnancy, third trimester O15.1 Eclampsia in labor O15.2 Eclampsia in the puerperium O15.9 Eclampsia, unspecified as to time period O16 Unspecified maternal hypertension O16.1 Unspecified maternal hypertension, first trimester O16.2 Unspecified maternal hypertension, second trimester O16.3 Unspecified maternal hypertension, third trimester O16.4 Unspecified maternal hypertension, complicating childbirth O16.5 Unspecified maternal hypertension, complicating the puerperium O16.9 Unspecified maternal hypertension, unspecified trimester Diabetes ( includes gestational) E10 Type 1 diabetes mellitus E10.10 Type 1 diabetes mellitus with ketoacidosis without coma E10.11 Type 1 diabetes mellitus with ketoacidosis with coma E10.21 Type 1 diabetes mellitus with diabetic nephropathy E10.22 Type 1 diabetes mellitus with diabetic chronic kidney disease E10.29 Type 1 diabetes mellitus with other diabetic kidney complication E Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema E Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema E Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema E Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema E Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema E Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema E Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema E Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema E Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema E Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula E Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula E Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment E Type 1 diabetes mellitus with stable proliferative diabetic retinopathy V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 7

8 Diabetes ( includes gestational) (con.'t) E Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema E10.36 Type 1 diabetes mellitus with diabetic cataract E10.37 Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment E10.39 Type 1 diabetes w oth diabetic ophthalmic complication E10.40 Type 1 diabetes mellitus with diabetic neuropathy, unspecified E10.41 Type 1 diabetes mellitus with diabetic mononeuropathy E10.42 Type 1 diabetes mellitus with diabetic polyneuropathy E10.43 Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy E10.44 Type 1 diabetes mellitus with diabetic amyotrophy E10.49 Type 1 diabetes mellitus with other diabetic neurological complication E10.51 Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene E10.52 Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene E10.59 Type 1 diabetes mellitus with other circulatory complications E Type 1 diabetes mellitus with diabetic neuropathic arthropathy E Type 1 diabetes mellitus with other diabetic arthropathy E Type 1 diabetes mellitus with diabetic dermatitis E Type 1 diabetes mellitus with foot ulcer E Type 1 diabetes mellitus with other skin ulcer E Type 1 diabetes mellitus with other skin complications E Type 1 diabetes mellitus with periodontal disease E Type 1 diabetes mellitus with other oral complications E Type 1 diabetes mellitus with hypoglycemia with coma E Type 1 diabetes mellitus with hypoglycemia without coma E10.65 Type 1 diabetes mellitus with hyperglycemia E10.69 Type 1 diabetes mellitus with other specified complication E10.8 Type 1 diabetes mellitus with unspecified complications E10.9 Type 1 diabetes mellitus without complications E11 Type 2 diabetes mellitus E11.00 Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic hyperosmolar coma (NKHHC) E11.01 Type 2 diabetes mellitus with hyperosmolarity with coma E11.10 Type 2 diabetes mellitus with ketoacidosis without coma E11.11 Type 2 diabetes mellitus with ketoacidosis with coma E11.21 Type 2 diabetes mellitus with diabetic nephropathy E11.22 Type 2 diabetes mellitus with diabetic chronic kidney disease E11.29 Type 2 diabetes mellitus with other diabetic kidney complication E Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema E Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema E Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema E Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema E Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema E Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema E Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema E Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema E Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 8

9 Diabetes ( includes gestational) (con.'t) E Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula E Type 2 diabetes mellitus with prolifera ve diabe c re nopathy with trac on re nal detachment not involving the macula E Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment E Type 2 diabetes mellitus with stable proliferative diabetic retinopathy E Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema E11.36 Type 2 diabetes mellitus with diabetic cataract E11.37 Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment E11.39 Type 2 diabetes mellitus with other diabetic ophthalmic complication E11.40 Type 2 diabetes mellitus with diabetic neuropathy, unspecified E11.41 Type 2 diabetes mellitus with diabetic mononeuropathy E11.42 Type 2 diabetes mellitus with diabetic polyneuropathy E11.43 Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy E11.44 Type 2 diabetes mellitus with diabetic amyotrophy E11.49 Type 2 diabetes mellitus with other diabetic neurological complication E11.51 Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene E11.52 Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene E11.59 Type 2 diabetes mellitus with other circulatory complications E Type 2 diabetes mellitus with diabetic neuropathic arthropathy E Type 2 diabetes mellitus with other diabetic arthropathy E Type 2 diabetes mellitus with diabetic dermatitis E Type 2 diabetes mellitus with foot ulcer E Type 2 diabetes mellitus with other skin ulcer E Type 2 diabetes mellitus with other skin complications E Type 2 diabetes mellitus with periodontal disease E Type 2 diabetes mellitus with other oral complications E Type 2 diabetes mellitus with hypoglycemia with coma E Type 2 diabetes mellitus with hypoglycemia without coma E11.65 Type 2 diabetes mellitus with hyperglycemia E11.69 Type 2 diabetes mellitus with other specified complication E11.8 Type 2 diabetes mellitus with unspecified complications E11.9 Type 2 diabetes mellitus without complications E13 Other specified diabetes mellitus E13.00 Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic hyperosmolar coma (NKHHC) E13.01 Other specified diabetes mellitus with hyperosmolarity with coma E13.10 Other specified diabetes mellitus with ketoacidosis without coma E13.11 Other specified diabetes mellitus with ketoacidosis with coma E13.21 Other specified diabetes mellitus with diabetic nephropathy E13.22 Other specified diabetes mellitus with diabetic chronic kidney disease E13.29 Other specified diabetes mellitus with other diabetic kidney complication E Other specified diabetes mellitus with unspecified diabetic retinopathy with macular edema E Other specified diabetes mellitus with unspecified diabetic retinopathy without macular edema E Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema E Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema E Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 9

10 Diabetes ( includes gestational) (con.'t) E Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema E Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema E Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema E Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema E Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula E Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula E Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment E Other specified diabetes mellitus with stable proliferative diabetic retinopathy E Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema E13.36 Other specified diabetes mellitus with diabetic cataract E13.37 Other specified diabetes mellitus with diabetic macular edema, resolved following treatment E13.39 Other specified diabetes mellitus with other diabetic ophthalmic complication E13.40 Other specified diabetes mellitus with diabetic neuropathy, unspecified E13.41 Other specified diabetes mellitus with diabetic mononeuropathy E13.42 Other specified diabetes mellitus with diabetic polyneuropathy E13.43 Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy E13.44 Other specified diabetes mellitus with diabetic amyotrophy E13.49 Other specified diabetes mellitus with other diabetic neurological complication E13.51 Other specified diabetes mellitus with diabetic peripheral angiopathy without gangrene E13.52 Other specified diabetes mellitus with diabetic peripheral angiopathy with gangrene E13.59 Other specified diabetes mellitus with other circulatory complications E Other specified diabetes mellitus with diabetic neuropathic arthropathy E Other specified diabetes mellitus with other diabetic arthropathy E Other specified diabetes mellitus with diabetic dermatitis E Other specified diabetes mellitus with foot ulcer E Other specified diabetes mellitus with other skin ulcer E Other specified diabetes mellitus with other skin complications E Other specified diabetes mellitus with periodontal disease E Other specified diabetes mellitus with other oral complications E Other specified diabetes mellitus with hypoglycemia with coma E Other specified diabetes mellitus with hypoglycemia without coma E13.65 Other specified diabetes mellitus with hyperglycemia E13.69 Other specified diabetes mellitus with other specified complication E13.8 Other specified diabetes mellitus with unspecified complications E13.9 Other specified diabetes mellitus without complications O24 Diabetes mellitus in pregnancy, childbirth, and the puerperium O24.01 Pre existing type 1 diabetes mellitus, in pregnancy O Pre existing type 1 diabetes mellitus, in pregnancy, first trimester O Pre existing type 1 diabetes mellitus, in pregnancy, second trimester O Pre existing type 1 diabetes mellitus, in pregnancy, third trimester O Pre existing type 1 diabetes mellitus, in pregnancy, unspecified trimester O24.02 Pre existing type 1 diabetes mellitus, in childbirth O24.03 Pre existing type 1 diabetes mellitus, in the puerperium O Pre existing type 2 diabetes mellitus, in pregnancy, first trimester V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 10

11 Diabetes ( includes gestational) (con.'t) O Pre existing type 2 diabetes mellitus, in pregnancy, second trimester O Pre existing type 2 diabetes mellitus, in pregnancy, third trimester O Pre existing type 2 diabetes mellitus, in pregnancy, unspecified trimester O24.12 Pre existing type 2 diabetes mellitus, in childbirth O24.13 Pre existing type 2 diabetes mellitus, in the puerperium O24.31 Unspecified pre existing diabetes mellitus in pregnancy O Unspecified pre existing diabetes mellitus in pregnancy, first trimester O Unspecified pre existing diabetes mellitus in pregnancy, second trimester O Unspecified pre existing diabetes mellitus in pregnancy, third trimester O Unspecified pre existing diabetes mellitus in pregnancy, unspecified trimester O24.32 Unspecified pre existing diabetes mellitus in childbirth O24.33 Unspecified pre existing diabetes mellitus in the puerperium O Gestational diabetes mellitus in pregnancy, diet controlled O Gestational diabetes mellitus in pregnancy, insulin controlled O Gestational diabetes mellitus in pregnancy, controlled by oral hypoglycemic drugs O Gestational diabetes mellitus in pregnancy, unspecified control O Gestational diabetes mellitus in childbirth, diet controlled O Gestational diabetes mellitus in childbirth, insulin controlled O Gestational diabetes mellitus in childbirth, controlled by oral hypoglycemic drugs O Gestational diabetes mellitus in childbirth, unspecified control O Gestational diabetes mellitus in the peurperium, diet controlled O Gestational diabetes mellitus in the peurperium, insulin controlled O Gestational diabetes mellitus in the puerperium, controlled by oral hypoglycemic drugs O Gestational diabetes mellitus in the puerperium, unspecified control O Other pre existing diabetes mellitus in pregnancy, first trimester O Other pre existing diabetes mellitus in pregnancy, second trimester O Other pre existing diabetes mellitus in pregnancy, third trimester O Other pre existing diabetes mellitus in pregnancy, unspecified trimester O24.82 Other pre existing diabetes mellitus in childbirth O24.83 Other pre existing diabetes mellitus in the puerperium O Unspecified diabetes mellitus in pregnancy, first trimester O Unspecified diabetes mellitus in pregnancy, second trimester O Unspecified diabetes mellitus in pregnancy, third trimester O Unspecified diabetes mellitus in pregnancy, unspecified trimester O24.92 Unspecified diabetes mellitus in childbirth O24.93 Unspecified diabetes mellitus in the puerperium O Abnormal glucose complicating pregnancy O Abnormal glucose complicating childbirth O Abnormal glucose complicating the puerperium V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 11

12 Asthma O Diseases of the respiratory system complicating pregnancy, first trimester O Diseases of the respiratory system complicating pregnancy, second trimester O Diseases of the respiratory system complicating pregnancy, third trimester O Diseases of the respiratory system complicating pregnancy, unspecified trimester O99.52 Diseases of the respiratory system complicating childbirth O99.53 Diseases of the respiratory system complicating the puerperium J45 Asthma J45.20 Mild intermittent asthma, uncomplicated J45.21 Mild intermittent asthma with (acute) exacerbation J45.22 Mild intermittent asthma with status asthmaticus J45.30 Mild persistent asthma, uncomplicated J45.31 Mild persistent asthma with (acute) exacerbation J45.32 Mild persistent asthma with status asthmaticus J45.40 Moderate persistent asthma, uncomplicated J45.41 Moderate persistent asthma with (acute) exacerbation J45.42 Moderate persistent asthma with status asthmaticus J45.50 Severe persistent asthma, uncomplicated J45.51 Severe persistent asthma with (acute) exacerbation J45.52 Severe persistent asthma with status asthmaticus J Unspecified asthma with (acute) exacerbation J Unspecified asthma with status asthmaticus J Unspecified asthma, uncomplicated J Exercise induced bronchospasm J Cough variant asthma J Other asthma Tobacco Use O Smoking (tobacco) complicating pregnancy, unspecified trimester O Smoking (tobacco) complicating pregnancy, first trimester O Smoking (tobacco) complicating pregnancy, second trimester O Smoking (tobacco) complicating pregnancy, third trimester O Smoking (tobacco) complicating childbirth O Smoking (tobacco) complicating the puerperium Thyroid Disease O90.5 Postpartum thyroiditis O Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester O Endocrine, nutritional and metabolic diseases complicating pregnancy, first trimester O Endocrine, nutritional and metabolic diseases complicating pregnancy, second trimester O Endocrine, nutritional and metabolic diseases complicating pregnancy, third trimester O Endocrine, nutritional and metabolic diseases complicating childbirth O Endocrine, nutritional and metabolic diseases complicating the puerperium Psychiatric Disease O Other mental disorders complicating pregnancy, unsp trimester O Other mental disorders complicating pregnancy, first trimester V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 12

13 Psychiatric Disease (con.'t) O Other mental disorders comp pregnancy, second trimester O Other mental disorders complicating pregnancy, third trimester O Other mental disorders complicating childbirth O Other mental disorders complicating the puerperium F53 Mental and behavioral disorders associated with the puerperium, not elsewhere classified Seizure Disorder O Diseases of the nervous system complicating pregnancy, unspecified trimester O Diseases of the nervous system complicating pregnancy, first trimester O Diseases of the nervous system complicating pregnancy, second trimester O Diseases of the nervous system complicating pregnancy, third trimester O Diseases of the nervous system complicating childbirth O Diseases of the nervous system complicating the puerperium V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 13

14 Pregnancy Characteristics Multiple Gestation Z37.2 Twins, both inborn Z37.3 Twins, one liveborn and one stillborn Z37.4 Twins, both stillborn Z37.50 Multiple births, unspecified, all liveborn Z37.51 Triplets, all liveborn Z37.52 Quadruplets, all liveborn Z37.53 Quintuplets, all liveborn Z37.54 Sextuplets, all liveborn Z37.59 Other multiple births, all liveborn Z37.60 Multiple births, unspecified, some liveborn Z37.61 Triplets, some liveborn Z37.62 Quadruplets, some liveborn Z37.63 Quintuplets, some liveborn Z37.64 Sextuplets, some liveborn Z37.69 Other multiple births, some liveborn Z37.7 Other multiple births, all stillborn Prior Cesarean Delivery O Maternal care for low transverse scar from previous cesarean delivery O Maternal care for vertical scar from previous cesarean delivery O Maternal care for unspecified type scar from previous cesarean delivery Preterm Delivery/Labor O Preterm premature rupture of membranes, onset of labor within 24 hours of rupture, first trimester O Preterm premature rupture of membranes, onset of labor within 24 hours of rupture, second trimester O Preterm premature rupture of membranes, onset of labor within 24 hours of rupture, third trimester O Preterm premature rupture of membranes, onset of labor within 24 hours of rupture, unspecified trimester O Preterm premature rupture of membranes, onset of labor more than 24 hours following rupture, first trimester O Preterm premature rupture of membranes, onset of labor more than 24 hours following rupture, second trimester O Preterm premature rupture of membranes, onset of labor more than 24 hours following rupture, third trimester O Preterm premature rupture of membranes, onset of labor more than 24 hours following rupture, unspecified trimeste O first trimester O second trimester O third trimester O unspecified trimester O60.10 Preterm labor with preterm delivery, unspecified trimester O60.12 Preterm labor second trimester with preterm delivery second trimester O60.13 Preterm labor second trimester with preterm delivery third trimester O60.14 Preterm labor third trimester with preterm delivery third trimester Abnormal Placentation O44 Placenta previa O44.00 Complete placenta previa NOS or without hemorrhage, unspecified trimester O44.01 Complete placenta previa NOS or without hemorrhage, first trimester O44.02 Complete placenta previa NOS or without hemorrhage, second trimester O44.03 Complete placenta previa NOS or without hemorrhage, third trimester V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 14

15 Pregnancy Characteristics Abnormal Placentation (con.'t) O44.10 Complete placenta previa with hemorrhage, unspecified trimester O44.11 Complete placenta previa with hemorrhage, first trimester O44.12 Complete placenta previa with hemorrhage, second trimester O44.13 Complete placenta previa with hemorrhage, third trimester O44.20 Partial placenta previa NOS or without hemorrhage, unspecified trimester O44.21 Partial placenta previa NOS or without hemorrhage, first trimester O44.22 Partial placenta previa NOS or without hemorrhage, second trimester O44.23 Partial placenta previa NOS or without hemorrhage, third trimester O44.30 Partial placenta previa with hemorrhage, unspecified trimester O44.31 Partial placenta previa with hemorrhage, first trimester O44.32 Partial placenta previa with hemorrhage, second trimester O44.33 Partial placenta previa with hemorrhage, third trimester O44.40 Low lying placenta NOS or without hemorrhage, unspecified trimester O44.41 Low lying placenta NOS or without hemorrhage, first trimester O44.42 Low lying placenta NOS or without hemorrhage, second trimester O44.43 Low lying placenta NOS or without hemorrhage, third trimester O44.50 Low lying placenta with hemorrhage, unspecified trimester O44.51 Low lying placenta with hemorrhage, first trimester O44.52 Low lying placenta with hemorrhage, second trimester O44.53 Low lying placenta with hemorrhage, third trimester O45 Premature separation of placenta [abruption placentae] O Premature separation of placenta with coagulation defect, unspecified, first trimester O Premature separation of placenta with coagulation defect, unspecified, second trimester O Premature separation of placenta with coagulation defect, unspecified, third trimester O Premature separation of placenta with coagulation defect, unspecified, unspecified trimester O Premature separation of placenta with afibrinogenemia, first trimester O Premature separation of placenta with afibrinogenemia, second trimester O Premature separation of placenta with afibrinogenemia, third trimester O Premature separation of placenta with afibrinogenemia, unspecified trimester O Premature separation of placenta with disseminated intravascular coagulation, first trimester O Premature separation of placenta with disseminated intravascular coagulation, second trimester O Premature separation of placenta with disseminated intravascular coagulation, third trimester O Premature separation of placenta with disseminated intravascular coagulation, unspecified trimester O Premature separation of placenta with other coagulation defect, first trimester O Premature separation of placenta with other coagulation defect, second trimester O Premature separation of placenta with other coagulation defect, third trimester O Premature separation of placenta with other coagulation defect, unspecified trimester O45.8X1 Other premature separation of placenta, first trimester O45.8X2 Other premature separation of placenta, second trimester O45.8X3 Other premature separation of placenta, third trimester O45.8X9 Other premature separation of placenta, unspecified trimester O45.90 Premature separation of placenta, unspecified, unspecified trimester O45.91 Premature separation of placenta, unspecified, first trimester O45.92 Premature separation of placenta, unspecified, second trimester V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 15

16 Pregnancy Characteristics Abnormal Placentation (con.'t) O45.93 Premature separation of placenta, unspecified, third trimester O Placenta accreta, first trimester O Placenta accreta, second trimester O Placenta accreta, third trimester O Placenta accreta, unspecified trimester O Placenta increta, first trimester O Placenta increta, second trimester O Placenta increta, third trimester O Placenta increta, unspecified trimester O Placenta percreta, first trimester O Placenta percreta, second trimester O Placenta percreta, third trimester O Placenta percreta, unspecified trimester O69.4 Labor and delivery complicated by vasa previa V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 16

17 Payer Mix Definitions Public: Medicare Medicaid Champus/Tricare HMO/Medicaid Other Government Private: Other: Uninsured/ Self pay: Unknown/ Missing: Blue Cross Commercial Insurance HMO Worker's Comp Other Self Free Care Unknown/Missing V18.2 SPECIAL REPORT 2019 NPIC NPIC.ORG 17

Medical Policy An independent licensee of the Blue Cross Blue Shield Association.

Medical Policy An independent licensee of the Blue Cross Blue Shield Association. Insulin Pump Page 1 of 12 Medical Policy An independent licensee of the Blue Cross Blue Shield Association. Title: Insulin Pump Professional Original Effective Date: January 1, 1999 Revision Date(s): June

More information

Therapeutic Shoes for Diabetics

Therapeutic Shoes for Diabetics Last Review Date: August 11, 2017 Number: MG.MM.DM.03bC8v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Glycated Hemoglobin/Glycated Protein

Glycated Hemoglobin/Glycated Protein 190.21 - Glycated Hemoglobin/Glycated Protein The management of diabetes mellitus requires regular determinations of blood glucose levels. Glycated hemoglobin/protein levels are used to assess long-term

More information

Hypoglycemics, Lantus Insulin

Hypoglycemics, Lantus Insulin Texas Prior Authorization Program PDL Edit Criteria Drug/Drug Class Hypoglycemics, Lantus Insulin Information Included in this Document Hypoglycemics, Lantus Insulin Drugs requiring prior authorization:

More information

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are page 1 Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Anthem Blue Cross Life and Health Insurance Company are independent licensees of the Blue Cross Association.

More information

Continuous Glucose Monitoring System

Continuous Glucose Monitoring System Continuous Glucose Monitoring System Policy Number: Original Effective Date: MM.02.003 03/13/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2016 Section: DME Place(s)

More information

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus

Asthma J45.20 Mild, uncomplicated J45.21 Mild, with (acute) exacerbation J45.22 Mild, with status asthmaticus A Fib & Flutter I48.0 Paroxysmal atrial fibrillation I48.1 Persistent atrial fibrillation I48.2 Chronic atrial fibrillation I48.3 Typical atrial flutter Asthma J45.20 Mild, uncomplicated J45.21 Mild, with

More information

Continuous Glucose Monitoring System

Continuous Glucose Monitoring System Continuous Glucose Monitoring System Policy Number: Original Effective Date: MM.02.003 03/13/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2017 Section: DME Place(s)

More information

Continuous Glucose Monitoring System

Continuous Glucose Monitoring System Continuous Glucose Monitoring System Policy Number: Original Effective Date: MM.02.003 03/13/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 4/1/2018 Section: DME Place(s)

More information

revolutionehr.com 2019 Clinical Quality Measure Scoring Guide

revolutionehr.com 2019 Clinical Quality Measure Scoring Guide revolutionehr.com 2019 Clinical Quality Measure Scoring Guide Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by health care providers. These

More information

2017 Clinical Quality Measures

2017 Clinical Quality Measures 2017 Clinical Quality Measures Clinical quality measures, or CQMs, are statistics that seek to quantify the quality of services performed by health care providers. These statistics involve data related

More information

Fee for Service Pay for Performance Program Guidelines Program Year

Fee for Service Pay for Performance Program Guidelines Program Year Fee for Service Pay for Performance Program Guidelines 2018 Program Year 2 General Program Guidelines Table of Contents General Program Guidelines... 4 Program Overview... 4 Provider Participation Eligibility...

More information

Provider Bulletin December 2018 Coding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes

Provider Bulletin December 2018 Coding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes Medi-Cal Managed Care L. A. Care Provider Bulletin December 2018 provider guide to coding the diagnosis and treatment of diabetes Diabetes mellitus is a chronic disorder caused by either an absolute decrease

More information

Coding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes

Coding spotlight: diabetes provider guide to coding the diagnosis and treatment of diabetes Medicaid Managed Care December 2018 provider guide to coding the diagnosis and treatment of diabetes Diabetes mellitus is a chronic disorder caused by either an absolute decrease in the amount of insulin

More information

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Combination Agents

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Combination Agents Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Combination Agents This criteria was recommended for review by an MCO to ensure appropriate

More information

Expanded Fall Risk Factors, Locations of Data Extraction, and Coding. Diastolic blood pressure value (mmhg) Calculated body mass index

Expanded Fall Risk Factors, Locations of Data Extraction, and Coding. Diastolic blood pressure value (mmhg) Calculated body mass index Appendix B Expanded Fall Risk Factors, Locations of Data Extraction, and Coding Factor Location Coding Blood pressure systolic Blood pressure diastolic Body mass index Systolic blood pressure value (mmhg)

More information

Highlights of the NEW 2017 Codes ICD-10- CM

Highlights of the NEW 2017 Codes ICD-10- CM Highlights of the NEW 2017 Codes ICD-10- CM Maine HIMA September 22, 2016 ICD-10-CM o 1943 New Codes o 422 Revised Codes o 305 Deleted Codes Overall Picture o Which revisions apply most to your facility?

More information

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document DPP-4 Inhibitor Criteria A: Alogliptin 6.25mg, Januvia 25mg, Nesina 6.25mg, Onglyza

More information

Contractor Information. LCD Information. Local Coverage Determination (LCD): HOMOCYSTeine Level, Serum (L34419) Document Information

Contractor Information. LCD Information. Local Coverage Determination (LCD): HOMOCYSTeine Level, Serum (L34419) Document Information Local Coverage Determination (LCD): HOMOCYSTeine Level, Serum (L34419) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor

More information

Medical Policy Original Effective Date: Revised Date: Page 1 of 23

Medical Policy Original Effective Date: Revised Date: Page 1 of 23 Page 1 of 23 Disclaimer Description Coverage Determination Refer to the member s specific benefit plan and Schedule of Benefits to determine coverage. This may not be a benefit on all plans or the plan

More information

Optum360 Learning: Detailed Instruction for Appropriate ICD-10-CM Coding

Optum360 Learning: Detailed Instruction for Appropriate ICD-10-CM Coding Optum360 Learning: Detailed Instruction for Appropriate Coding An educational guide to the structure, conventions, and guidelines of coding 2017 Contents Section 1: Introduction...1 Documentation...7 Documentation

More information

Medical Policy Original Effective Date: April 1999 Revised Date: 07/25/2018 Page 1 of 36

Medical Policy Original Effective Date: April 1999 Revised Date: 07/25/2018 Page 1 of 36 Page 1 of 36 Content This includes the following items: 1. Home Blood Glucose Monitors: Prior Authorization is not required. 2. Insulin pumps, cartridges and reservoirs. Prior Authorization is not required.

More information

Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Retirement Date N/A

Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Retirement Date N/A Local Coverage Determination (LCD): Laparoscopic Sleeve Gastrectomy for Severe Obesity (L34238) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor

More information

COMPREHENSIVE DIABETES CARE

COMPREHENSIVE DIABETES CARE COMPREHENSIVE DIABETES CARE APPLICATIONS OBJECTIVE Purpose of Measure: ELIGIBLE POPULATION Which members are included? STANDARD OF CARE What screening should be done? HbA1c Eye Exam Blood Pressure Nephropathy

More information

Continuous Glucose Monitoring (CGM)

Continuous Glucose Monitoring (CGM) Continuous Glucose Monitoring (CGM) Date of Origin: 02/2001 Last Review Date: 08/22/2018 Effective Date: 08/22/2018 Dates Reviewed: 04/2004, 04/2005, 03/2006, 11/2006, 12/2007, 03/2008, 09/2008, 04/2009,

More information

Texas Prior Authorization Program Clinical Edit Criteria

Texas Prior Authorization Program Clinical Edit Criteria Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Thiazolidinediones Clinical Edit Information Included in this Document Thiazolidinediones Drugs requiring prior authorization: the

More information

Byetta (Exenatide Injection)

Byetta (Exenatide Injection) Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization

More information

ICD What Are You Waiting For? Presented by Jennifer Warfield, BSN, HCS-D, COS-C Education Director, PPS Plus Software

ICD What Are You Waiting For? Presented by Jennifer Warfield, BSN, HCS-D, COS-C Education Director, PPS Plus Software ICD-10... What Are You Waiting For? Presented by Jennifer Warfield, BSN, HCS-D, COS-C Education Director, PPS Plus Software ICD-10... What Are You Waiting For? What is it? International classification

More information

FY 2011 WISEWOMAN Approved ICD-9 Code List

FY 2011 WISEWOMAN Approved ICD-9 Code List 243 Congenital hypothyroidism 245.0 Thyroiditis; Acute thyroiditis 245.1 Thyroiditis; Subacute thyroiditis 245.2 Thyroiditis; Chronic lymphocytic thyroiditis 245.3 Thyroiditis; Chronic fibrous thyroiditis

More information

GLUCOSE TESTING-BLOOD

GLUCOSE TESTING-BLOOD 648.83 ABNORMAL GLUCOSE TOLERANCE COMPLICATING PREGNANCY, CHILDBIRTH OR THE PUERPERIUM, ANTEPARTUM CONDITION OR 648.84 ABNORMAL GLUCOSE TOLERANCE COMPLICATING PREGNANCY, CHILDBIRTH OR THE PUERPERIUM, POSTPARTUM

More information

Nevada Journal of Public Health, (2010). Vol. 7 Shen et al., 27

Nevada Journal of Public Health, (2010). Vol. 7 Shen et al., 27 Nevada Journal of Public Health, (2010). Vol. 7 Shen et al., 27 Adverse Maternal Outcomes in Nevada: Does Asthma Matter? Jay J. Shen, Ph.D. Department of Health Care Administration and Policy School of

More information

Accepted. Original Article. I-Ting Liu 1, Ru-Yi Huang 1,2, Cheuk-Kwan Sun 3,4,Chi-Wei Lin 1,2

Accepted. Original Article. I-Ting Liu 1, Ru-Yi Huang 1,2, Cheuk-Kwan Sun 3,4,Chi-Wei Lin 1,2 E-Da Medical Journal 2017;4(4):10-18 Original Article The Prognosis and Healthcare Expenditure of Newly Diagnosed Diabetic Patients Are There Differences Between Family Physicians and the Internists? I-Ting

More information

Contractor Information. LCD Information. FUTURE Local Coverage Determination (LCD): Routine Foot Care (L35138) Document Information

Contractor Information. LCD Information. FUTURE Local Coverage Determination (LCD): Routine Foot Care (L35138) Document Information FUTURE Local Coverage Determination (LCD): Routine Foot Care (L35138) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Please note: Future Effective

More information

CONTINUOUS GLUCOSE MONITORING AND INSULIN DELIVERY FOR MANAGING DIABETES

CONTINUOUS GLUCOSE MONITORING AND INSULIN DELIVERY FOR MANAGING DIABETES UnitedHealthcare Community Plan Medical Policy CONTINUOUS GLUCOSE MONITORING AND INSULIN DELIVERY FOR MANAGING DIABETES Policy Number: CS024.M Effective Date: October 1, 2018 Table of Contents Page INSTRUCTIONS

More information

Where Are You on the ICD-10-CM Radar Screen? Presented to the Indiana Medical Group Management Association

Where Are You on the ICD-10-CM Radar Screen? Presented to the Indiana Medical Group Management Association Where Are You on the ICD-10-CM Radar Screen? Presented to the Indiana Medical Group Management Association ICD-10 Final Rule On January 16, 2009, the U.S. Department of Health and Human Services (HHS)

More information

CONTINUOUS GLUCOSE MONITORING AND INSULIN DELIVERY FOR MANAGING DIABETES

CONTINUOUS GLUCOSE MONITORING AND INSULIN DELIVERY FOR MANAGING DIABETES UnitedHealthcare of California (HMO) UnitedHealthcare Benefits Plan of California (EPO/POS) UnitedHealthcare of Oklahoma, Inc. UnitedHealthcare of Oregon, Inc. UnitedHealthcare Benefits of Texas, Inc.

More information

Learning Objectives. Novant Health. Novant Health Ambulatory CDI: How We ve Grown!

Learning Objectives. Novant Health. Novant Health Ambulatory CDI: How We ve Grown! 1 Novant Health Ambulatory CDI: How We ve Grown! Yvonne Whitley, RN, BSN, CPC, CRC, CDEO Supervisor, Novant Health Medical Group Clinical Documentation Improvement Novant Health Winston Salem, NC Learning

More information

ICD-10 Physician Education. General Surgery

ICD-10 Physician Education. General Surgery ICD-10 Physician Education General Surgery 1 Training Objectives ICD-9 to ICD-10 Comparison Documentation Tips Additional Educational Opportunities Questions 2 ICD-9 to ICD-10 Comparison Code Structure

More information

Evidence-Based Population Health Management through Analytics

Evidence-Based Population Health Management through Analytics Evidence-Based Population Health Management through Analytics Presented to: Human Factor Analytics, Inc. Slide 1 What can a geological principle teach us about risk management? Human Factor Analytics,

More information

FY 2017 ICD-10-CM Guideline Updates. Melanie Endicott, MBA/HCM, RHIA, CHDA, CDIP, CCS, CCS-P, FAHIMA, AHIMA-Approved ICD-10-CM/PCS Trainer

FY 2017 ICD-10-CM Guideline Updates. Melanie Endicott, MBA/HCM, RHIA, CHDA, CDIP, CCS, CCS-P, FAHIMA, AHIMA-Approved ICD-10-CM/PCS Trainer FY 2017 ICD-10-CM Guideline Updates Melanie Endicott, MBA/HCM, RHIA, CHDA, CDIP, CCS, CCS-P, FAHIMA, AHIMA-Approved ICD-10-CM/PCS Trainer How to Review Guideline Changes 1. Download the FY 2017 ICD-10-CM

More information

Risk Adjustment Documentation & Coding Improvement Reference Information for 2017

Risk Adjustment Documentation & Coding Improvement Reference Information for 2017 Risk Adjustment Documentation & Coding Improvement Reference Information for 2017 In today s quality and patient-centered health care environment, the importance of accurate, specific and thorough medical

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Artificial Pancreas Device Systems Page 1 of 15 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Artificial Pancreas Device Systems Professional Institutional Original

More information

2 Master the ICD 10 Payment System to Prevent Revenue Losses

2 Master the ICD 10 Payment System to Prevent Revenue Losses Master the ICD 10 Payment System to Prevent Revenue Losses Tricia A. Twombly BSN RN HCS D HCS O COS C CHCE AHIMA Approved ICD 10 CM Trainer Senior Director, DecisionHealth Chief Executive Officer, BMSC

More information

Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification

Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Diagnose and Procedures Codes 1. ICD-9-CM definition of

More information

ICD-10-CM: The Sage Continues

ICD-10-CM: The Sage Continues ICD-10-CM: The Sage Continues UHIMA Kathy DeVault, MSL, RHIA, CCS, CCS-P, FAHIMA UASI Kathy.devault@uasisolutions.com Objectives Review quality documentation Discuss use of unspecified codes Discuss opportunities

More information

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15 1 1500 MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS 1 1501 MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS 1 1502 MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS 1 1503 MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS 1

More information

Management of Pregestational and Gestational Diabetes Mellitus

Management of Pregestational and Gestational Diabetes Mellitus Background and Prevalence Management of Pregestational and Gestational Diabetes Mellitus Pregestational Diabetes - 8 million women in the US are affected, complicating 1% of all pregnancies. Type II is

More information

Medical Policy Routine Foot Care and Debridement of Toenails

Medical Policy Routine Foot Care and Debridement of Toenails Medical Policy Routine Foot Care and Debridement of Toenails Table of Contents Policy: Commercial Coding Information Information Pertaining to All Policies Policy: Medicare Description Endnotes Authorization

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Long Term Use Continuous Glucose Monitoring of Interstitial Fluid MP-040-MD-DE Medical Management Provider Notice Date: 04/15/2018;

More information

3/20/2017. CONNECTING THE LATEST GUIDANCE FY2017 FOR ICD-10 MATTERS Kyla D. Harrison, RN, BSN, HCS-D, COS-C Visiting Nurse Association of Kansas City

3/20/2017. CONNECTING THE LATEST GUIDANCE FY2017 FOR ICD-10 MATTERS Kyla D. Harrison, RN, BSN, HCS-D, COS-C Visiting Nurse Association of Kansas City CONNECTING THE LATEST GUIDANCE FY2017 FOR ICD-10 MATTERS Kyla D. Harrison, RN, BSN, HCS-D, COS-C Visiting Nurse Association of Kansas City Coding needs met in many different ways: 1. Fulltime Coders HCS-D

More information

Present-on-Admission (POA) Coding

Present-on-Admission (POA) Coding 1 Present-on-Admission (POA) Coding Michael Pine, MD, MBA Michael Pine and Associates, Inc 2 POA and Coding Guidelines (1) Unless otherwise specified, a POA modifier must be assigned to each principal

More information

GLUCOSE TESTING-BLOOD

GLUCOSE TESTING-BLOOD Abnormal glucose tolerance complicating pregnancy, childbirth or the 648.83 puerperium, antepartum condition or complication Abnormal glucose tolerance complicating pregnancy, childbirth or the 648.84

More information

Episodes of Care Risk Adjustment

Episodes of Care Risk Adjustment Episodes of Care Risk Adjustment Episode Types Wave 1 Asthma Acute Exacerbation Perinatal Total Joint Replacement Wave 2 Acute Percutaneous Coronary Intervention COPD Acute Exacerbation Non-acute Percutaneous

More information

CONTINUOUS GLUCOSE MONITORING AND INSULIN DELIVERY FOR MANAGING DIABETES

CONTINUOUS GLUCOSE MONITORING AND INSULIN DELIVERY FOR MANAGING DIABETES UnitedHealthcare Commercial Medical Policy CONTINUOUS GLUCOSE MONITORING AND INSULIN DELIVERY FOR MANAGING DIABETES Policy Number: END002 Effective Date: February 1, 2019 Table of Contents Page INSTRUCTIONS

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Artificial Pancreas Device Systems Page 1 of 16 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Artificial Pancreas Device Systems Professional Institutional Original

More information

ASSIGNMENT 5-1 REVIEW QUESTIONS

ASSIGNMENT 5-1 REVIEW QUESTIONS ASSIGNMENT 5-1 REVIEW QUESTIONS Part I Fill in the Blank on ICD-9-CM 1. primary, principal 2. Systematized Nomenclature of Human and Veterinary Medicine (SNOMED) International. 3. International Classification

More information

Appendix 1: Supplementary tables [posted as supplied by author]

Appendix 1: Supplementary tables [posted as supplied by author] Appendix 1: Supplementary tables [posted as supplied by author] Table A. International Classification of Diseases, Ninth Revision, Clinical Modification Codes Used to Define Heart Failure, Acute Myocardial

More information

Supplemental figure 1. Adjusted odds ratios for gestational diabetes, pre-eclampsia, premature birth and miscarriage for women with and without PCOS.

Supplemental figure 1. Adjusted odds ratios for gestational diabetes, pre-eclampsia, premature birth and miscarriage for women with and without PCOS. Supplemental figure 1 Adjusted odds ratios for gestational diabetes, pre-eclampsia, premature birth and miscarriage for women with and without PCOS. * Denominator is all pregnancies, adjusted for age,

More information

CHAPTERS OF ICD-10-CM

CHAPTERS OF ICD-10-CM CHAPTERS OF ICD-10-CM Chapter Description Category Chapter 1 Certain Infectious and parasitic diseases A00-B99 Chapter 2 Neoplasms C00-D49 Chapter 3 Diseases of the blood and blood-forming organs and certain

More information

2018 Diagnosis Coding Fact Sheet

2018 Diagnosis Coding Fact Sheet The information contained in this document is provided for informational purposes only and represents no statement, promise, or guarantee by Cordis Corporation concerning levels of reimbursement, payment,

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): 3/1/2012 Most Recent Review Date (Revised): 4/11/2018 Effective Date: 8/1/2018 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER

More information

Appendix A: List of Clinical Classification Software Diagnostic Categories Excluded from Calculation of HIV-Related Inpatient Days

Appendix A: List of Clinical Classification Software Diagnostic Categories Excluded from Calculation of HIV-Related Inpatient Days supplemental digitai content Appendix A: List of Clinical Classification Software Diagnostic Categories Excluded from Calculation of HIV-Related Inpatient Days CCS Category Description 80 Multiple sclerosis

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Khera R, Dharmarajan K, Wang Y, et al. Association of the hospital readmissions reduction program with mortality during and after hospitalization for acute myocardial infarction,

More information

Medical Complications of Pregnancy

Medical Complications of Pregnancy Medical Complications of Pregnancy Systems Cardiovascular Pulmonary Endocrine Gastrointestinal Urologic Neurologic Cardiovascular System Physiologic anemia 3:1 increase of plasma volume:rbc mass Treat

More information

A chapter by chapter look at the ICD-10-CM code set Coding Tip Sheet

A chapter by chapter look at the ICD-10-CM code set Coding Tip Sheet Coding Tip Sheet Chapter 1 - Certain Infectious and Parasitic Diseases Terminology changes: The term Sepsis (ICD-10-CM) has replaced the term Septicemia (ICD-9-CM) Urosepsis is a nonspecific term and is

More information

Reminder: NPIC/QAS CME/CEU Program

Reminder: NPIC/QAS CME/CEU Program V.12.2 Special Report: Perinatal Complications associated with Gestational and Pregestational Diabetes I. Introduction Diabetes mellitus is a metabolic disease characterized by chronic hyperglycemia and

More information

FY 2017 Updates to the ICD-10- CM and ICD-10-PCS Official Guidelines for Coding and Reporting

FY 2017 Updates to the ICD-10- CM and ICD-10-PCS Official Guidelines for Coding and Reporting FY 2017 Updates to the ICD-10- CM and ICD-10-PCS Official Guidelines for Coding and Reporting Nelly Leon-Chisen, RHIA Director, Coding and Classification American Hospital Association Guidelines Accompany

More information

Documentation for the IRF Provider

Documentation for the IRF Provider Documentation for the IRF Provider Timothy N. Brundage, MD, CCDS Certified Clinical Documentation Specialist DrBrundage@gmail.com 1 Medicare controls the ball field If you want to play ball, you have to

More information

We know these take time to gather, so please plan ahead!

We know these take time to gather, so please plan ahead! CDL AND INSULIN CHECKLIST Are you a CDL holder who uses insulin for diabetes? As of November 2018, you can get certified to drive faster, with no waiver application process! Please bring all of the following:

More information

ICD-10-CM Recertification Prep: Proper Prepping Isn t as Bad as You Think

ICD-10-CM Recertification Prep: Proper Prepping Isn t as Bad as You Think ICD-10-CM Recertification Prep: Proper Prepping Isn t as Bad as You Think Julie Orton Van, CPC, CPC-P, CEMC Product Manager Coding Solutions 2015 AAPC HEALTHCON, Las Vegas NV Publisher s Notice: Although

More information

To be considered medically necessary, an eligible provider must prescribe all orthotics.

To be considered medically necessary, an eligible provider must prescribe all orthotics. Original Issue Date (Created): 2/1/2018 Most Recent Review Date (Revised): 9/26/2017 Effective Date: 4/1/2018 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER

More information

Revenue Cycle Solutions Consulting & Management Services Why Words Matter Through an Endocrinology Lens 2015 The Advisory Board Company advisory.

Revenue Cycle Solutions Consulting & Management Services Why Words Matter Through an Endocrinology Lens 2015 The Advisory Board Company advisory. Revenue Cycle Solutions Consulting & Management Services Why Words Matter Through an Endocrinology Lens Key Objectives for Today s Session 1. Develop understanding of the role documentation plays in determining

More information

Determining MS-DRGs. Kimberly Cunningham CPC, CIC, CCS. Copyright/Disclaimer text

Determining MS-DRGs. Kimberly Cunningham CPC, CIC, CCS. Copyright/Disclaimer text Determining MS-DRGs Kimberly Cunningham CPC, CIC, CCS Copyright/Disclaimer text No part of this presentation may be reproduced or transmitted in any form or by any means (graphically, electronically, or

More information

Diabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016

Diabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016 Diabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016 Medical Director Sweet Success Sutter Medical Center Sacramento Perinatal Associates of Sacramento

More information

Lipids Testing

Lipids Testing Previously Listed as Edit 12 190.23 - Lipids Testing Lipoproteins are a class of heterogeneous particles of varying sizes and densities containing lipid and protein. These lipoproteins include cholesterol

More information

Learning Objectives. Guidance Hierarchy. AHA Coding Clinic Update

Learning Objectives. Guidance Hierarchy. AHA Coding Clinic Update 1 AHA Coding Clinic Update Nelly Leon Chisen, RHIA Director, Coding and Classification Executive Editor, Coding Clinic American Hospital Association Chicago, IL Learning Objectives At the completion of

More information

Appendix Identification of Study Cohorts

Appendix Identification of Study Cohorts Appendix Identification of Study Cohorts Because the models were run with the 2010 SAS Packs from Centers for Medicare and Medicaid Services (CMS)/Yale, the eligibility criteria described in "2010 Measures

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Dharmarajan K, Wang Y, Lin Z, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. doi:10.1001/jama.2017.8444 etable

More information

TABLE I-1: RESIDENT INFANT DEATHS PER 1,000 LIVE BIRTHS, BY RACE AND ETHNICITY, FLORIDA AND UNITED STATES, CENSUS YEARS AND

TABLE I-1: RESIDENT INFANT DEATHS PER 1,000 LIVE BIRTHS, BY RACE AND ETHNICITY, FLORIDA AND UNITED STATES, CENSUS YEARS AND TABLE I-1: RESIDENT INFANT DEATHS PER 1,000 LIVE BIRTHS, BY RACE AND ETHNICITY, FLORIDA AND UNITED STATES, CENSUS YEARS 1970-2000 AND 2004-2014 FLORIDA 1 UNITED STATES 1 YEAR WHITE2 BLACK2 HISPANIC3 WHITE2

More information

Common Diagnosis Codes and Tips for Coding Nicotine Use/

Common Diagnosis Codes and Tips for Coding Nicotine Use/ ICD-10 Tobacco Billing Guide ICD-10 and Tobacco Common Diagnosis Codes and Tips for Coding Nicotine Use/ Dependence Tobacco use is the leading cause of preventable disease and death in the United States,

More information

ACOFP 55th Annual Convention & Scientific Seminars. How Complicated is Your Panel? Effective Risk Coding in Primary Care. Alison Mancuso, DO, FACOFP

ACOFP 55th Annual Convention & Scientific Seminars. How Complicated is Your Panel? Effective Risk Coding in Primary Care. Alison Mancuso, DO, FACOFP 8 ACOFP 55th Annual Convention & Scientific Seminars How Complicated is Your Panel? Effective Risk Coding in Primary Care Alison Mancuso, DO, FACOFP How Complicated is Your Panel?: Effective Risk Coding

More information

ICD-10 Physician Education. Palliative Care SIP

ICD-10 Physician Education. Palliative Care SIP ICD-10 Physician Education Palliative Care SIP 1 Training Objectives ICD-9 to ICD-10 Comparison Documentation Tips Additional Educational Opportunities Questions 2 ICD-9 to ICD-10 Comparison Code Structure

More information

Selected tables standardised to Segi population

Selected tables standardised to Segi population Selected tables standardised to Segi population LIST OF TABLES Table 4.2S: Selected causes of death, all-ages, 2000 2004 (Segi Standard) Table 5.3S: Public hospitalisations by major cause of admission

More information

Looking Toward State Health Assessment.

Looking Toward State Health Assessment. CONNECTICUT DEPARTMENT OF PUBLIC HEALTH Policy, Planning and Analysis. Looking Toward 2000 - State Health Assessment. Table of Contents Glossary Maps Appendices Publications Public Health Code PP&A Main

More information

APPENDIX EXHIBITS. Appendix Exhibit A2: Patient Comorbidity Codes Used To Risk- Standardize Hospital Mortality and Readmission Rates page 10

APPENDIX EXHIBITS. Appendix Exhibit A2: Patient Comorbidity Codes Used To Risk- Standardize Hospital Mortality and Readmission Rates page 10 Ross JS, Bernheim SM, Lin Z, Drye EE, Chen J, Normand ST, et al. Based on key measures, care quality for Medicare enrollees at safety-net and non-safety-net hospitals was almost equal. Health Aff (Millwood).

More information

Thyroid Testing

Thyroid Testing 190.22 - Thyroid Testing Thyroid function studies are used to delineate the presence or absence of hormonal abnormalities of the thyroid and pituitary glands. These abnormalities may be either primary

More information

2A's+R ASK about tobacco use: "Do you currently smoke or use otherforms of tobacco?" ADVISE the patient to quit: "Quitting tobacco is one of the best thingsyou can do for your health. I strongly encourage

More information

Clinical Policy Title: Artificial pancreas device system

Clinical Policy Title: Artificial pancreas device system Clinical Policy Title: Artificial pancreas device system Clinical Policy Number: 08.02.07 Effective Date: April 1, 2016 Initial Review Date: November 18, 2015 Most Recent Review Date: February 6, 2018

More information

Agenda. American Diabetes Association Diabetic Complications Diabetes Coding Guidelines & ICD-10 Codes Documentation

Agenda. American Diabetes Association Diabetic Complications Diabetes Coding Guidelines & ICD-10 Codes Documentation Diabetes Agenda American Diabetes Association Diabetic Complications Diabetes Coding Guidelines & ICD-10 Codes Documentation American Diabetes Association American Diabetes Association Diabetic Eye Complications

More information

Vision and Eye Health Surveillance

Vision and Eye Health Surveillance Vision and Eye Health Surveillance Panel moderator: Jeff Todd, Prevent Blindness 500 Cities: Local Data for Better Health Measures Tracked UNHEALTHY BEHAVIORS Binge Drinking Current Smoking No Leisure

More information

Recognizing Racial Ethnic Disparities in Maternity Care

Recognizing Racial Ethnic Disparities in Maternity Care Recognizing Racial Ethnic Disparities in Maternity Care Louise Marie Roth, PhD Associate Professor of Sociology, University of Arizona Racial-Ethnic Disparities in Health Outcomes Black Americans suffer

More information

Diabetes Mellitus. and coding the complications that can occur

Diabetes Mellitus. and coding the complications that can occur Diabetes Mellitus and coding the complications that can occur As a coder.don t get stuck in neutral You have to keep moving forward with the new compliances and codes Diabetes Mellitus with. let s take

More information

DIABETES MEASURES GROUP OVERVIEW

DIABETES MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: DIABETES MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN DIABETES MEASURES GROUP: #1. Diabetes: Hemoglobin A1c Poor Control #2. Diabetes: Low Density Lipoprotein (LDL-C)

More information

APR-DRG Description Ave Charge

APR-DRG Description Ave Charge Abdominal Pain 16,500.25 2.8 6,000.09 Acute & Subacute Endocarditis 15,339.30 3.0 5,113.10 Acute Myocardial Infarction 17,687.46 2.6 6,802.87 Alcohol Abuse & Dependence 19,126.64 4.2 4,553.96 Alcoholic

More information

Pregestational and Gestational Diabetes

Pregestational and Gestational Diabetes Pregestational and Gestational Diabetes Francis S. Nuthalapaty, MD Greenville Health System University of South Carolina School of Medicine - Greenville Case History 30 year old black female presents to

More information

Counseling and Long-term Follow up After Gestational Disorders

Counseling and Long-term Follow up After Gestational Disorders Counseling and Long-term Follow up After Gestational Disorders Tanya Melnik, MD Assistant Professor, University of Minnesota Sarina Martini, MD Ob/Gyn Resident, PGY4 University of Minnesota Counseling

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Readmission Measures Set

More information

ICD-10-CM for Home Health Outreach Staff Webcast #2. Referral Data: Impact Overview

ICD-10-CM for Home Health Outreach Staff Webcast #2. Referral Data: Impact Overview ICD-10-CM for Home Health Outreach Staff Webcast #2 Patricia W. Tulloch RN, BSN, MSN, HCS-D RBC Limited Healthcare & Management Consultants P: 845-889-8128 E: rbc@netstep.net www.rbclimited.com Integrated

More information

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5). Appendix Definitions of Index Admission and Readmission Definitions of index admission and readmission follow CMS hospital-wide all-cause unplanned readmission (HWR) measure as far as data are available.

More information